Search by Drug Name or NDC

NDC 00078-0911-94 Xiidra 50 mg/mL Details

Xiidra 50 mg/mL

Xiidra is a OPHTHALMIC SOLUTION/ DROPS in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is LIFITEGRAST.

MedlinePlus Drug Summary

Ophthalmic lifitegrast is used to treat the signs and symptoms of dry eye disease. Lifitegrast is in a class of medications called lymphocyte function-associated antigen-1 (LFA-1) antagonist. Lifitegrast works by reducing the swelling in the eye tissues.

Related Packages: 00078-0911-94
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Lifitegrast Ophthalmic

Product Information

NDC	00078-0911
Product ID	0078-0911_d4d1ca2a-8c29-477e-bdd1-7e536daa28cf
Associated GPIs	86734050002020
GCN Sequence Number	076360
GCN Sequence Number Description	lifitegrast DROPERETTE 5 % OPHTHALMIC
HIC3	Q2C
HIC3 Description	OPHTHALMIC ANTI-INFLAMMATORY IMMUNOMODULATOR-TYPE
GCN	41847
HICL Sequence Number	043610
HICL Sequence Number Description	LIFITEGRAST
Brand/Generic	Brand
Proprietary Name	Xiidra
Proprietary Name Suffix	n/a
Non-Proprietary Name	Lifitegrast
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	SOLUTION/ DROPS
Route	OPHTHALMIC
Active Ingredient Strength	50
Active Ingredient Units	mg/mL
Substance Name	LIFITEGRAST
Labeler Name	Novartis Pharmaceuticals Corporation
Pharmaceutical Class	Lymphocyte Function-Associated Antigen-1 Antagonist [EPC], Lymphocyte Function-Associated Antigen-1 Antagonists [MoA]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA208073
Listing Certified Through	2024-12-31

Package

NDC 00078-0911-94 (00078091194)

Pricing Information	N/A
NDC Package Code	0078-0911-94
Billing NDC	00078091194
Package	4 POUCH in 1 CARTON (0078-0911-94) / 5 AMPULE in 1 POUCH (0078-0911-95) / .2 mL in 1 AMPULE
Marketing Start Date	2020-06-04
NDC Exclude Flag	N